Oral evidence transcript
| Published on: | Monday 3 December 2018 |
|---|---|
| Date: | Wednesday 28 November 2018 |
| Meeting on: | Wednesday 28 November 2018 |
| Part of event segment: | Untitled |
| Document ID: | 157809 |
| Citations: |
|
Committees
Work packages
-
Brexit and the implications for UK business inquiry
Thursday 14 September 2017 - Thursday 14 September 2017
Witnesses
-
Mike Thompson, Chief Executive, Association of the British Pharmaceutical Industry, Mark Hicken, Chair of the American Pharmaceutical Group and Managing Director, Janssen UK, Pinder Sahota, General Manager and Corporate VP, Novo Nordisk UK